Publications

Found 102 results
[ Type(Desc)] Year
Journal Article
CA Gersbach, T Gaj, RM Gordley, and CF Barbas. "Directed evolution of recombinase specificity by split gene reassembly." Nucleic Acids Research 38, no. 12 (2010): 4198-4206.
PI Thakore, JB Black, IB Hilton, and CA Gersbach. "Editing the epigenome: technologies for programmable transcription and epigenetic modulation." Nature Methods 13, no. 2 (2016): 127-137.
IB Hilton, and CA Gersbach. "Enabling functional genomics with genome engineering." Genome research 25, no. 10 (2015): 1442-1455.
CA Gersbach. "Engineered bioactive molecules." 5 (2011): 131-145.
LR Polstein, M Juhas, G Hanna, N Bursac, and CA Gersbach. "An Engineered Optogenetic Switch for Spatiotemporal Control of Gene Expression, Cell Differentiation, and Tissue Morphogenesis." ACS Synthetic Biology 6, no. 11 (2017): 2003-2013.
CA Gersbach. "Engineered Proteins for Controlling Gene Expression." Handbook of Stem Cells 1 (2013): 125-138.
CA Gersbach. "Engineered Proteins for Controlling Gene Expression." Principles of Regenerative Medicine (2011): 159-176.
CE Nelson, and CA Gersbach. "Engineering Delivery Vehicles for Genome Editing." Annual Review of Chemical and Biomolecular Engineering 7, no. 1 (2016): 637-662.
AM Kabadi, and CA Gersbach. "Engineering synthetic TALE and CRISPR/Cas9 transcription factors for regulating gene expression." Methods 69, no. 2 (2014): 188-197.
AM Kabadi, and CA Gersbach. "Engineering synthetic TALE and CRISPR/Cas9 transcription factors for regulating gene expression." Methods 69, no. 2 (2014): 188-197.
AM Kabadi, PI Thakore, CM Vockley, DG Ousterout, TM Gibson, F Guilak, TE Reddy, and CA Gersbach. "Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain." ACS Synthetic Biology 4, no. 6 (2015): 689-699.
IB Hilton, AM D'Ippolito, CM Vockley, PI Thakore, GE Crawford, TE Reddy, and CA Gersbach. "Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers." Nature Biotechnology 33, no. 5 (2015): 510-517.
DG Ousterout, P Perez-Pinera, PI Thakore, AM Kabadi, MT Brown, X Qin, O Fédrigo, V Mouly, JP Tremblay, and CA Gersbach. "Erratum: Reading Frame correction by targeted genome editing restores dystrophin expression in cells from duchenne muscular dystrophy patients (Molecular Therapy (2013) 21 (1718-1726) DOI: 10.1038/mt.2013.111)." Molecular Therapy 21, no. 11 (2013): 2130-.
R Barrangou, and CA Gersbach. "Expanding the CRISPR Toolbox: Targeting RNA with Cas13b." Molecular Cell 65, no. 4 (2017): 582-584.
CL Duvall, A Prokop, CA Gersbach, and JM Davidson. "Gene Delivery into Cells and Tissues." (2013): 687-723.
P Perez-Pinera, DG Ousterout, MT Brown, and CA Gersbach. "Gene targeting to the ROSA26 locus directed by engineered zinc finger nucleases." Nucleic Acids Research 40, no. 8 (2012): 3741-3752.
JN Robinson-Hamm, and CA Gersbach. "Gene therapies that restore dystrophin expression for the treatment of Duchenne muscular dystrophy." Human Genetics 135, no. 9 (2016): 1029-1040.
J Huang, M Chen, MJ Whitley, H-C Kuo, ES Xu, A Walens, YM Mowery, D Van Mater, WC Eward, DM Cardona et al. "Generation and comparison of CRISPR-Cas9 and Cre-mediated genetically engineered mouse models of sarcoma." Nature Communications 8 (2017).
IB Hilton, and CA Gersbach. "Genetic engineering: Chemical control for CRISPR editing." Nature Chemical Biology 13, no. 1 (2016): 2-3.
CA Gersbach, JE Phillips, and AJ García. "Genetic engineering for skeletal regenerative medicine." Annual Review of Biomedical Engineering 9 (2007): 87-119.
JA Doudna, and CA Gersbach. "Genome editing: the end of the beginning." Genome Biology 16, no. 1 (2015).
CE Nelson, JN Robinson-Hamm, and CA Gersbach. "Genome engineering: a new approach to gene therapy for neuromuscular disorders." Nature Reviews Neurology 13, no. 11 (2017): 647-661.
SS Adkar, JM Brunger, VP Willard, C-L Wu, CA Gersbach, and F Guilak. "Genome Engineering for Personalized Arthritis Therapeutics." Trends in Molecular Medicine 23, no. 10 (2017): 917-931.
JM Brunger, A Zutshi, VP Willard, CA Gersbach, and F Guilak. "Genome Engineering of Stem Cells for Autonomously Regulated, Closed-Loop Delivery of Biologic Drugs." Stem Cell Reports 8, no. 5 (2017): 1202-1213.
CA Gersbach. "Genome engineering: the next genomic revolution." Nature Methods 11, no. 10 (2014): 1009-1011.

Pages